全文获取类型
收费全文 | 30796篇 |
免费 | 2019篇 |
国内免费 | 180篇 |
专业分类
耳鼻咽喉 | 88篇 |
儿科学 | 1500篇 |
妇产科学 | 613篇 |
基础医学 | 2339篇 |
口腔科学 | 118篇 |
临床医学 | 2859篇 |
内科学 | 8227篇 |
皮肤病学 | 467篇 |
神经病学 | 2009篇 |
特种医学 | 253篇 |
外科学 | 2961篇 |
综合类 | 1097篇 |
一般理论 | 6篇 |
预防医学 | 5746篇 |
眼科学 | 947篇 |
药学 | 1461篇 |
1篇 | |
中国医学 | 83篇 |
肿瘤学 | 2220篇 |
出版年
2024年 | 6篇 |
2023年 | 239篇 |
2022年 | 141篇 |
2021年 | 282篇 |
2020年 | 348篇 |
2019年 | 129篇 |
2018年 | 460篇 |
2017年 | 495篇 |
2016年 | 548篇 |
2015年 | 533篇 |
2014年 | 455篇 |
2013年 | 737篇 |
2012年 | 2143篇 |
2011年 | 3217篇 |
2010年 | 1178篇 |
2009年 | 944篇 |
2008年 | 2756篇 |
2007年 | 2598篇 |
2006年 | 2311篇 |
2005年 | 2407篇 |
2004年 | 2716篇 |
2003年 | 2722篇 |
2002年 | 2108篇 |
2001年 | 1473篇 |
2000年 | 495篇 |
1999年 | 277篇 |
1998年 | 223篇 |
1997年 | 159篇 |
1996年 | 121篇 |
1995年 | 90篇 |
1994年 | 111篇 |
1993年 | 67篇 |
1992年 | 62篇 |
1991年 | 52篇 |
1990年 | 62篇 |
1989年 | 45篇 |
1988年 | 39篇 |
1987年 | 54篇 |
1986年 | 34篇 |
1985年 | 26篇 |
1984年 | 25篇 |
1983年 | 13篇 |
1982年 | 15篇 |
1981年 | 17篇 |
1980年 | 15篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1970年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
2.
Scott R. Bauer MD ScM Peggy M. Cawthon PhD MPH Kristine E. Ensrud MD Anne M. Suskind MD MS John C. Newman MD PhD Howard A. Fink MD MPH Kaiwei Lu MS Rebecca Scherzer PhD Andrew R. Hoffman MD Kenneth Covinsky MD Lynn M. Marshall ScD For the Osteoporotic Fractures in Men Research Group 《Journal of the American Geriatrics Society》2022,70(4):1082-1094
3.
Gender as an effect modifier in the relationship between hypertension and reticular pseudodrusen in patients with early or intermediate age-related macular degeneration 下载免费PDF全文
Nathaniel Gelinas Anne M. Lynch Marc T. Mathias Alan G. Palestine Naresh Mandav Karen L Christopher Jennifer L. Patnaik; University of Colorado Retina Research Group 《国际眼科》2022,15(3):461-465
AIM: To determine whether the prevalence of treated hypertension is higher among males or females with early/intermediate (e/i) age-related macular degeneration (AMD) with and without bilateral reticular pseudodrusen (RPD).
METHODS: Retrospective review of the records of patients with e/iAMD who were recruited into the University of Colorado AMD registry between July 2014 and November 2019. Images were classified using the Beckman Initiative criteria and presence/absence of RPD. Patients were categorized into three groups: 1) e/iAMD with RPD; 2) e/iAMD without RPD; 3) control patients who did not have AMD. Multinomial logistic regression analysis was used for adjusted analysis with odds ratios (OR) and confidence intervals (CI).
RESULTS: There were 260 patients with e/iAMD of which 101 had bilateral RPD and 159 had no RPD, and 221 controls. Overall, 62% of patients were female and the three groups did not differ by gender. When stratified by gender, the female e/iAMD/RPD group had a higher prevalence of hypertension, 64.1% vs 45.2% for controls, OR=2.2 (95%CI: 1.2-4.0). The frequency of hypertension in the e/iAMD/no RPD group was 54.1% and did not significantly differ from the control group. Among males, prevalence rates of treated hypertension did not differ. There is a significant interaction of hypertension and gender for the e/iAMD/RPD group such that women with e/iAMD who had RPD were significantly more likely to have hypertension (P=0.042). This relationship was not significant in the e/iAMD/no RPD group (P=0.269).
CONCLUSION: Among females treated hypertension is significantly higher among e/iAMD/RPD patients, whereas for males there is no significant association. 相似文献
4.
Klemen Dovc MD Michelle Van Name MD Barbara Jenko Bizjan PhD Ewa Rusak MD Claudia Piona MD Gul Yesiltepe-Mutlu MD Rosaline Mentink MD Giulio Frontino MD Maddalena Macedoni MD Sofia Helena Ferreira MD Joana Serra-Caetano MD Júlia Galhardo MD Julie Pelicand MD Francesca Silvestri MD Jennifer Sherr MD Agata Chobot MD Torben Biester MD for the ISPAD JENIOUS Group 《Diabetes, obesity & metabolism》2022,24(3):564-569
5.
6.
7.
《慢性阻塞性肺疾病免疫调节治疗专家共识》撰写组 《中国全科医学》2022,25(24):2947-2959
慢性阻塞性肺疾病(简称慢阻肺)是我国重点防治的慢性呼吸系统疾病之一,深入探讨慢阻肺的免疫发病机制并对其中的关键靶点进行干预可能为慢阻肺的防治提供新办法。基于目前临床常用的慢阻肺免疫调节剂相关研究证据及具有免疫治疗作用的药物研发现状和趋势,《慢性阻塞性肺疾病免疫调节治疗专家共识》撰写组提出4条推荐意见:(1)细菌溶解产物、磷酸二酯酶抑制剂、大环内酯类药物等生物、化学制剂均可通过增强机体免疫功能和提高免疫细胞活性而发挥对慢阻肺的免疫调节作用;(2)针对流感病毒、肺炎球菌感染等进行疫苗接种可预防慢阻肺急性加重、降低患者死亡率;(3)他汀类药物及维生素D等具有免疫调节作用,对慢阻肺可能有一定的治疗作用,但二者在慢阻肺中的应用证据较少且存在一定不良反应,仍需进一步积累证据;(4)中医药复方及虫草制剂或可通过调节机体免疫功能、提高免疫细胞活性改善慢阻肺稳定期患者生活质量,减少急性加重。本专家共识旨在进一步推动我国慢阻肺免疫调节治疗的临床实践。 相似文献
8.
GD单抗治疗神经母细胞瘤临床应用协作组 《临床儿科杂志》2022,40(1):14-20
神经母细胞瘤(neuroblastoma,NB)是儿童最常见的颅外实体肿瘤,临床表现及预后具有高度异质性。低危患儿预后较好,高危患儿即使接受化疗、放疗、手术、造血干细胞移植等多种方法的综合治疗,长期存活率仍不足50%。探索潜在的治疗靶点对于提高高危患者的生存率具有重要意义。双唾液酸神经节苷脂抗原GD2在NB细胞高表达,达妥昔单抗β可与NB细胞膜表面过表达的GD2特定靶点结合,触发抗体依赖性细胞介导的细胞毒性作用和补体依赖的细胞毒性效应,通过双重免疫机制而发挥抗肿瘤作用。通过总结国外多项关键临床研究,并结合在海南和天津医疗先行区的上市前初步应用经验,我们对达妥昔单抗β的安全性、有效性、适用人群及使用方法进行总结和推荐,提出本共识,旨在为临床医师提供指导与帮助。 相似文献
9.
Seong Hee Kang Yuri Cho Soung Won Jeong Seung Up Kim Jin-Woo Lee On behalf of Korean NAFLD Study Group 《Clinical and molecular hepatology》2021,27(2):257
There is some dissatisfaction with the term “nonalcoholic fatty liver disease (NAFLD),” which overemphasizes alcohol and underemphasizes the importance of metabolic risk factors in this disease. Recently, a consensus recommended “metabolic (dysfunction)-associated fatty liver disease (MAFLD)” as a more appropriate term to describe fatty liver diseases (FLD) associated with metabolic dysfunction. During the definition change from NAFLD to MAFLD, subjects with FLD and metabolic abnormalities, together with other etiologies of liver diseases such as alcohol, virus, or medication who have been excluded from the NAFLD criteria, were added to the MAFLD criteria, while subjects with FLD but without metabolic abnormality, who have been included in the NAFLD criteria, were excluded from the MAFLD criteria. This means that there is an emphasis on the metabolic dysfunction in MAFLD which may underestimate the prognostic value of hepatic steatosis itself, whereas the MAFLD criteria might better identify subjects who are at a higher risk of hepatic or cardiovascular outcomes. However, non-metabolic risk NAFLD subjects who are excluded from the MAFLD criteria are missed from the diagnosis, and their potential risk can be the cause of future diseases. Although huge controversies remain, this review focused on summarizing recent studies that compared the clinical and prognostic characteristics between subjects with NAFLD and MAFLD. 相似文献
10.
Dagny Faksvåg Haugen Karl Ove Hufthammer Christina Gerlach Katrin Sigurdardottir Marit Irene Tuen Hansen Grace Ting Vilma Adriana Tripodoro Gabriel Goldraij Eduardo Garcia Yanneo Wojciech Leppert Katarzyna Wolszczak Lair Zambon Juliana Nalin Passarini Ivete Alonso Bredda Saad Martin Weber John Ellershaw Catriona Rachel Mayland the ERANet-LAC CODE Project Group 《The oncologist》2021,26(7):e1273-e1284